Pacific Biosciences of California Aktie
1,42
EUR
+0,01
EUR
+0,85
%
1,70
USD
-0,15
USD
-7,86
%
Werbung
Pacific Biosciences of California Aktie Analyse
| 19.10.18 | Pacific Biosciences of California Outperform | Cowen and Company, LLC | |
| 03.11.16 | Pacific Biosciences of California Buy | Cantor Fitzgerald | |
| 15.04.16 | Pacific Biosciences of California Overweight | First Analysis Securities | |
| 04.02.15 | Pacific Biosciences of California Buy | Maxim Group |
Werbung
Werbung